Seeking Alpha

Par Pharmaceutical (PRX +5%) agrees to acquire privately held Anchen Pharmaceuticals for $410M...

Par Pharmaceutical (PRX +5%) agrees to acquire privately held Anchen Pharmaceuticals for $410M in cash, a move that will boost the generic drug maker's current pipeline and add to its R&D capabilities.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs